- Home
- AIV vs EVMN Comparison
AIV vs EVMN Comparison
Compare AIV & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIV | EVMN |
|---|---|---|
| Founded | 1975 | 2020 |
| Country | United States | United States |
| Employees | N/A | 48 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 837.1M | 825.5M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | AIV | EVMN |
|---|---|---|
| Price | $4.23 | $21.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $10.00 | ★ $43.88 |
| AVG Volume (30 Days) | ★ 1.2M | 304.1K |
| Earning Date | 05-06-2026 | 06-11-2026 |
| Dividend Yield | ★ 87.41% | N/A |
| EPS Growth | ★ 616.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $138,486,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.94 | $13.89 |
| 52 Week High | $8.87 | $33.20 |
Technical Indicators
Market Signals| Indicator | AIV | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 47.78 | 36.33 |
| Support Level | $4.03 | $21.39 |
| Resistance Level | $4.30 | $23.08 |
| Average True Range (ATR) | 0.06 | 1.49 |
| MACD | 0.00 | -0.25 |
| Stochastic Oscillator | 42.86 | 8.30 |
Price Performance
Historical ComparisonAbout AIV Apartment Investment and Management Company
Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. Development and Redevelopment segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. Operating segment includes 20 residential apartment communities with 5,243 apartment homes that have achieved a stabilized level of operations. Other segment includes The Benson Hotel, company's only hotel. Majority of revenue is gained from Operating Segment.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.